| Literature DB >> 32405121 |
Avram E Denburg1, Wendy J Ungar2, Shiyi Chen3, Jeremiah Hurley4, Julia Abelson5.
Abstract
OBJECTIVE: Preferences of members of the public are recognized as important inputs into health care priority-setting, though knowledge of such preferences is scant. We sought to generate evidence of public preferences related to healthcare resource allocation among adults and children.Entities:
Keywords: Health system priority-setting; Public preferences; Resource allocation; Value-based healthcare
Mesh:
Year: 2020 PMID: 32405121 PMCID: PMC7219374 DOI: 10.1016/j.healthpol.2020.04.007
Source DB: PubMed Journal: Health Policy ISSN: 0168-8510 Impact factor: 2.980
Fig. 1Sample choice scenario.
Scenario: Chronic Disease Drug
Imagine that two different medicines are available to manage an incurable chronic blood disease: one drug treats the child form of the disease, while a different drug treats the adult form of the disease. Without treatment, patients die of the disease within 6 months of diagnosis. With drug treatment, both child and adult patients can be expected to live about 20 years from diagnosis, after which they usually die from progressive complications of the disease.
Each drug costs the same amount of money and would serve the same number of people. The health system can only afford to fund one of the two drugs at present, and cannot split the money between the two drugs.
Which drug should the health system director fund?
Please slide the bar to any point on the scale from -5 to +5 to show your strength of support for funding one of the drugs.
Fig. 2Moral reasoning exercise: Principles and rationales.
Fig. 3Unadjusted group mean preference scores across scenarios.
Circle = mean; centre line = median; box = interquartile range (IQR: 1st and 3rd quartiles of the data); whisker (inner fences): lower = 1st quartile - 1.5SD, upper = 3rd quartile + 1.5SD; suspected outliers are noted with a circle (control group) or plus sign (intervention group) beyond the upper and lower inner fences.
Impact of demographic and experimental variables on mean preference scores: Multiple regression mixed model results.
| Variable | Estimate | Standard Error | T value | p value |
|---|---|---|---|---|
| Intervention (vs control) | 0.72 | 0.14 | 5.40 | |
| Scenario | ||||
Liver transplant (vs chronic disease drug) | −0.02 | 0.11 | −0.16 | 0.87 |
Cancer therapy (vs chronic disease drug) | −1.30 | 0.11 | −11.78 | |
Palliative care (vs chronic disease drug) | 0.05 | 0.11 | 0.41 | 0.68 |
Eating disorders treatment (vs chronic disease drug) | −1.53 | 0.11 | −13.89 | |
| Group and scenario interaction | ||||
Intervention (vs control) and liver transplant (vs chronic disease drug) | −0.18 | 0.16 | −1.16 | 0.25 |
Intervention (vs control) and cancer therapy (vs chronic disease drug) | 0.22 | 0.16 | 1.42 | 0.16 |
Intervention (vs control) and palliative care (vs chronic disease drug) | −0.31 | 0.16 | −2.00 | 0.05 |
Intervention (vs control) and eating disorders (vs chronic disease drug) | 0.17 | 0.16 | 1.11 | 0.27 |
| Ontario (vs other regions) | 0.02 | 0.10 | 0.23 | 0.82 |
| Age categories | ||||
35 – 44 vs 18−34 | 0.35 | 0.14 | 2.39 | 0.02 |
45 – 54 vs 18−34 | 0.54 | 0.14 | 3.92 | |
55+ vs 18−34 | 0.71 | 0.14 | 5.06 | |
| Female | 0.12 | 0.09 | 1.30 | 0.19 |
| English (vs French) | −0.28 | 0.12 | −2.32 | 0.02 |
| Education: some college or higher | 0.04 | 0.13 | 0.29 | 0.77 |
| Full-time employment | −0.04 | 0.11 | −0.39 | 0.70 |
| Medium-to-high income (vs low income) | −0.40 | 0.20 | −1.99 | 0.05 |
| Good-to-excellent health (vs fair or poor) | 0.11 | 0.16 | 0.69 | 0.49 |
| Married or living with partner (vs single or divorced) | 0.06 | 0.10 | 0.55 | 0.58 |
| One or more children (i.e. parenthood) | −0.40 | 0.11 | −3.73 |
Overall model significance: Log-likelihood ratio tests suggest the full model is significantly better than a null model (LR = 1049.38, p < 0.0001), but reveals no significant difference in fit between the full and parsimonious models (LR = 14.1, df = 7, p = 0.95).
R2: The full model with predictors explained 9.7 % of within-subjects variance and 4.3 % of between-subjects variance, as compared with the null model (without predictors). Comparing the full model with a parsimonious model (non-significant predictors removed), the two models were almost identical. The parsimonious model explained 0.05 % more of the between-subjects variance; there was no difference in within-subjects variance explained.
Mean deviation of preference scores from zero difference between groups: Multiple regression mixed model results.
| Scenario | Intervention | Control | Difference | ||||
|---|---|---|---|---|---|---|---|
| Mean | 95 % CI | Mean | 95 % CI | Estimate | 95 % CI | p value | |
| Chronic disease | 0.25 | (-0.03, 0.53) | −0.47 | (-0.76, -0.18) | 0.72 | (0.46, 0.99) | <0.0001 |
| Liver transplant | 0.05 | (-0.23, 0.34) | −0.49 | (-0.78, -0.20) | 0.54 | (0.28, 0.80) | <0.0001 |
| Cancer therapy | −0.83 | (-1.11, -0.54) | −1.77 | (-2.06, -1.48) | 0.94 | (0.68, 1.21) | <0.0001 |
| Palliative care | −0.02 | (-0.30, 0.27) | −0.43 | (-0.72, -0.14) | 0.41 | (0.15, 0.67) | 0.0021 |
| Eating disorder treatment | −1.11 | (-1.39, -0.82) | −2.01 | (-2.30, -1.71) | 0.90 | (0.63, 1.16) | <0.0001 |
CI = confidence interval.
Participant selection of allocative principles by scenario.
| Principle | Overall (%) | Chronic disease drug | Liver transplant | Cancer therapy | Palliative care | Eating disorder treatment | Aggregate |
|---|---|---|---|---|---|---|---|
| Equal treatment | 57.75 | 55.24 | 58.99 | 54.33 | 63.91 | 56.27 | |
| Relief pain and suffering | 45.33 | 39.59 | 40.75 | 40.10 | 66.11 | 40.10 | |
| At risk of dying | 40.44 | 44.11 | 42.56 | 40.62 | 37.90 | 37.00 | 0.02 |
| Capacity to benefit longer | 24.89 | 19.53 | 24.71 | 34.54 | 15.91 | 29.75 | |
| Most vulnerable | 24.71 | 21.86 | 18.76 | 22.51 | 24.32 | 36.09 | |
| Evidence that it works | 24.14 | 25.87 | 26.65 | 23.42 | 20.44 | 24.32 | 0.04 |
| Live a full life | 20.65 | 19.15 | 17.98 | 24.71 | 17.21 | 24.19 | |
| Treat those dependent on others | 17.46 | 16.56 | 17.34 | 18.50 | 16.30 | 18.63 | 0.65 |
| Family responsibility | 16.56 | 24.71 | 20.57 | 14.23 | 13.07 | 10.22 | |
| Other considerations | 14.41 | 13.45 | 16.56 | 11.90 | 15.27 | 14.88 | 0.09 |
| Productive people | 10.45 | 16.04 | 14.10 | 7.89 | 7.50 | 6.73 | |
| Special people | 10.25 | 7.37 | 9.96 | 11.90 | 11.00 | 11.00 | 0.04 |
| Rare disease | 7.37 | 9.96 | 7.63 | 7.24 | 6.34 | 5.69 | 0.02 |
Statistically significant difference in proportion selecting the principle for indicated scenario compared to the chronic disease scenario at p < 0.01 level.
Test of equality of proportions across scenarios.
Fig. 4Odds of preference neutrality: Intervention vs. control.
p < 0.0002 for all comparisons